Basics NewAmsterdam Pharma Company IPO Date: February 9, 2021 Sector: Healthcare Industry: Biotech Market Cap: $4.11B Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 2.75% Avg Daily Range (30 D): $0.97 | 3.06% Avg Daily Range (90 D): $0.73 | 2.80% Institutional Daily Volume Avg Daily Volume: .37M Avg Daily Volume (30 D): 1.07M Avg Daily Volume (90 D): .87M Trade Size Avg Trade Size (Sh.): 93 Avg Trade Size (Sh.) (30 D): 82 Avg Trade Size (Sh.) (90 D): 85 Institutional Trades Total Inst.Trades: 806 Avg Inst. Trade: $1.53M Avg Inst. Trade (30 D): $2.1M Avg Inst. Trade (90 D): $1.7M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.42M Avg Closing Trade (30 D): $2.42M Avg Closing Trade (90 D): $1.68M Avg Closing Volume: 61.33K     News Aug 7, 2025 @ 12:21 AM NewAmsterdam (NAMS) Q2 Revenue Jumps 49% Source: Jesterai Jun 9, 2025 @ 11:00 AM NewAmsterdam Pharma Announces Positive Topline Alz... Source: N/A Jan 9, 2025 @ 8:38 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: N/A Dec 13, 2024 @ 10:16 PM NewAmsterdam Pharma Announces Closing of Upsized $... Source: N/A Dec 12, 2024 @ 2:37 AM NewAmsterdam Pharma Announces Pricing of Upsized $... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.61 $-.15 $-.34 Diluted EPS $-1.61 $-.15 $-.34 Revenue $ 64.01M $ 19.15M $ 2.98M Gross Profit $ $ $ Net Income / Loss $ -165.72M $ -17.36M $ -39.53M Operating Income / Loss $ -172.79M $ -35.64M $ -68.93M Cost of Revenue $ $ $ Net Cash Flow $ 123.96M $ -193.38M $ -27.09M PE Ratio